2005;8(6):46-49. Hearing loss that occurs instantaneously or over a period of a few days without immediately apparent cause is called Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL).

Ebselen is under clinical development by Sound Pharmaceuticals and currently in Phase II for Drug Toxicity. According to GlobalData, Phase II drugs for Drug Toxicity have a 65% phase transition ...

Ebselen is under clinical development by Sound Pharmaceuticals and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

The Coalition for Epidemic Preparedness Innovations (CEPI) has announced funding of up to $9.9 million for a groundbreaking vaccine safety project ...

Thomas scored 25 points in the loss off the bench and had a chance to tie the game at the end, but his attempt was unsuccessful. “Good screen... drew it up well. Got a great look... pretty sure ...

“The opportunity of providing the full complexity and spectrum of sound in children born ... in around 1% to 5% of cases of sensorineural hearing loss (SNHL), and is the most common form of ...

It works to process sound with: The average number of auditory nerve fibers can vary between ... A congenital malformation of the cochlear nerve—either aplasia (no nerve) or hypoplasia (small ...

Exposure to loud sounds and ototoxic drugs causes loss of these cell types and leads to sensorineural hearing loss. In the U.S. alone, over 13% of the U.S. population (30 million people) has some form ...

The Boston Celtics are navigating one of the most difficult periods in Joe Mazzulla’s era. Boston is 8-6 in December, with four of those losses coming in the last six games. Mazzulla’s team ...